Fenwick Represents Medical Device Company, Unlimited Tomorrow, in Financing Round with Prime Movers Lab
Fenwick represented Unlimited Tomorrow, Inc., a medical device company that develops next-generation prosthetic devices, in its seed financing round led by Prime Movers Lab, a VC fund that invests in breakthrough scientific startups.
More information can be obtained from this announcement.
The Fenwick transaction team included corporate principal Eli Curi and associates David Frydman and Najee Thorton.